Besides the involvement in amyloid clearance, a pathological feature of AD, CD33 may be regarded as a gene more generally involved in immune and inflammatory pathways, which are also altered in FTD (Ferrari et al., 2014, 2015). The gene discussed is CD33; the disease is Alzheimer disease.